Published in J Neuroimaging on April 01, 2001
Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science (1985) 5.81
Genetic linkage map of human chromosome 7 with 63 DNA markers. Proc Natl Acad Sci U S A (1987) 2.91
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology (1999) 2.72
A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature (1987) 2.02
Incidence and prevalence of epilepsy among older U.S. Medicare beneficiaries. Neurology (2012) 1.92
Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females. Hum Mol Genet (2001) 1.80
Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology (1999) 1.80
Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J Immunol (1994) 1.72
Bilateral parasagittal parietooccipital polymicrogyria and epilepsy. Ann Neurol (1997) 1.72
Significance of interictal temporal lobe delta activity for localization of the primary epileptogenic region. Neurology (1999) 1.49
Cognitive consequences of coexisting temporal lobe developmental malformations and hippocampal sclerosis. Neurology (1999) 1.48
Characterization of mutations in the gene doublecortin in patients with double cortex syndrome. Ann Neurol (1999) 1.47
Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia (1997) 1.41
Cortical abnormalities in epilepsy revealed by local EEG synchrony. Neuroimage (2007) 1.37
Bilateral porencephalic defect and bilateral perisylvian polymicrogyria. Brain Dev (1991) 1.37
Hippocampal sclerosis in temporal lobe epilepsy demonstrated by magnetic resonance imaging. Ann Neurol (1991) 1.34
Acute psychotic symptoms induced by topiramate. Seizure (1999) 1.34
Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging. Neurobiol Aging (2000) 1.26
Improved health care resource utilization following video-EEG-confirmed diagnosis of nonepileptic psychogenic seizures. Seizure (1998) 1.16
Weight loss associated with vagus nerve stimulation. Neurology (2002) 1.14
Familial perisylvian polymicrogyria: a new familial syndrome of cortical maldevelopment. Ann Neurol (2000) 1.13
Magnetic resonance spectroscopic imaging in temporal lobe epilepsy: neuronal dysfunction or cell loss? Arch Neurol (2001) 1.11
Subjective versus objective memory change after temporal lobe epilepsy surgery. Neurology (1999) 1.06
Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann Neurol (1995) 1.06
Epilepsy surgery outcome: comprehensive assessment in children. Neurology (1997) 1.05
Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice. Cell Immunol (1994) 1.05
Adult myoclonic epilepsy: a distinct syndrome of idiopathic generalized epilepsy. Neurology (2000) 1.04
Bullous pemphigoid antigen (BPAG1): cDNA cloning and mapping of the gene to the short arm of human chromosome 6. Genomics (1990) 0.96
Regulation of tyrosine hydroxylase activity in rat PC12 cells by neuropeptides of the secretin family. Mol Pharmacol (1989) 0.95
Frequency of epilepsy in patients with psychogenic seizures monitored by video-EEG. Neurology (2003) 0.95
Individual memory change after anterior temporal lobectomy: a base rate analysis using regression-based outcome methodology. Epilepsia (1998) 0.94
Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group. Epilepsia (1994) 0.93
Effect of electrosurgical technique on wound healing and early complication rate following abdominal dermolipectomy. Ann Plast Surg (1996) 0.93
In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy. Neurology (2001) 0.92
Ambulatory EEG monitoring. J Clin Neurophysiol (1999) 0.91
Human nidogen: complete amino acid sequence and structural domains deduced from cDNAs, and evidence for polymorphism of the gene. DNA (1989) 0.91
Altered brain sodium channel transcript levels in human epilepsy. Brain Res Mol Brain Res (1996) 0.91
Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy. A new syndrome. Brain (1988) 0.90
Bilateral hippocampal atrophy: consequences to verbal memory following temporal lobectomy. Neurology (2001) 0.89
Reimplantation of limbs. Plast Reconstr Surg (1967) 0.89
Metabolic networks in epilepsy by MR spectroscopic imaging. Acta Neurol Scand (2012) 0.88
Occipitoparietal epilepsy, hippocampal atrophy, and congenital developmental abnormalities. Epilepsia (2000) 0.86
Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults. Epilepsia (2001) 0.86
Cognitive correlates of 1H MRSI-detected hippocampal abnormalities in temporal lobe epilepsy. Neurology (1999) 0.86
Supplementary sensorimotor area epilepsy. Seizure localization, cortical propagation and subcortical activation pathways using ictal SPECT. Brain (1997) 0.84
Chronic temporal lobe epilepsy: spatial extent and degree of metabolic dysfunction studied with magnetic resonance spectroscopy (MRS). Epilepsy Res (2004) 0.84
Association of combined MRI, interictal EEG, and ictal EEG results with outcome and pathology after temporal lobectomy. Epilepsia (1997) 0.84
Verbal retention lateralizes patients with unilateral temporal lobe epilepsy and bilateral hippocampal atrophy. Epilepsia (2001) 0.83
Felbamate monotherapy for partial-onset seizures: an active-control trial. Neurology (1993) 0.82
Abnormalities of cortical thickness in postictal psychosis. Epilepsy Behav (2011) 0.82
Human laminin A chain (LAMA) gene: chromosomal mapping to locus 18p11.3. Genomics (1989) 0.82
Volumetric MRI of the limbic system: anatomic determinants. Neuroradiology (1998) 0.82
Proton magnetic resonance spectroscopy of brain-stem lesions. Neuroradiology (2002) 0.82
Relationships among hippocampal volumetry, proton magnetic resonance spectroscopy, and verbal memory in temporal lobe epilepsy. Epilepsia (2001) 0.81
Correlation of scalp EEG and 1H-MRS metabolic abnormalities in temporal lobe epilepsy. Epilepsia (2001) 0.81
Benign occipital epilepsy: a family study. Epilepsia (1987) 0.80
Myoclonus epilepsy and ragged-red fibres (MERRF). 2. Electrophysiological studies and comparison with other progressive myoclonus epilepsies. Brain (1989) 0.80
Major white matter fiber changes in medically intractable neocortical epilepsy in children: a diffusion tensor imaging study. Epilepsy Res (2012) 0.79
Eclampsia, hippocampal sclerosis, and temporal lobe epilepsy: accident or association? Neurology (2004) 0.79
Improved detection of human antibodies to a Plasmodium antigen using a peptide modified with Aib residues. J Pept Sci (1997) 0.78
Carotid-ophthalmic aneurysm: an uncommon cause of acute monocular blindness. CMAJ (1987) 0.78
Predictive value of MRI-identified mesial temporal sclerosis for surgical outcome in temporal lobe epilepsy: an intent-to-treat analysis. Epilepsia (2000) 0.77
Intracranial EEG electrodes. Neurology (1990) 0.75
Akinetic mutism caused by bilateral anterior cerebral tuberculous obliterative arteritis. Neurology (1990) 0.75
Identification of a recombination event narrowing the Lafora disease gene region. J Med Genet (1997) 0.75
Clinical efficacy of an endodontic antiseptic in a controlled release delivery system. Endod Dent Traumatol (1988) 0.75
Enhancing family therapy: the addition of a community resource specialist. J Marital Fam Ther (2001) 0.75
Familial Hydroxyapatite Chondrocalcinosis with Spondyloepiphyseal Dysplasia: Clinical Course and Absence of Genetic Linkage to the Type II Procollagen Gene. J Clin Rheumatol (1995) 0.75
Postictal stability of proton magnetic resonance spectroscopy imaging (1H-MRSI) ratios in temporal lobe epilepsy. Neurology (2001) 0.75
Contribution of neuropsychological data to the prediction of temporal lobe epilepsy surgery outcome. Epilepsia (1998) 0.75
An assessment of the reliability of race, Hispanic ethnicity, birthplace, and tobacco history data in the Massachusetts cancer registry, 2005-2009. J Registry Manag (2014) 0.75
Focal cortical dysplasia. J Neurosurg (1988) 0.75